12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

More documents

Recommendations

Info

Stollmann-Gibbels,B.; Testi,A.M.; van Wering,E.| R.; Zimmermann,M. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS) Leukemia. 13:376-385 (1999) Hasle,H.; Kerndrup,G.; Yssing,M.; Clausen,N.; Østergaard,E.; Jacobsen,N.; Jacobsen,B.B. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia. 10:1269-1273 (1996) Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277-282. Locatelli,F.; Pession,A.; Bonetti,F.; Maserati,E.; Prete,L.; Pedrazzoli,P.; Zecca,M.; Prete,A.; Paolucci,P.; Cazzola,M. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia. 8:844-849 (1994) Nichols,K.; Parsons,S.K.; Guinan,E. Long-term follow-up of 12 pediatric patients with primary myelodysplastic syndrome treated with HLA-identical sibling donor bone marrow transplantation [letter] Blood 87:4020-4022 (1996) Strahm,B., Locatelli,F., Bader,P., Ehlert,K., Kremens,B., Zintl,F., Fuhrer,M., Stachel,D., Sykora,K.W., Sedlacek,P., Baumann,I., & Niemeyer,C.M. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplantation, 40, 329-333 (2007). Strahm,B., Nollke,P., Zecca,M., Korthof,E.T., Bierings,M., Furlan,I., & Sedlacek,P el al. Hematopoietic stem cell transplantation for advanced MDS in children: results of the EWOG-MDS98 study. Leukemia, in press (2011) Yusuf,U., Frangoul,H.A., Gooley,T.A., Woolfrey,A.E., Carpenter,P.A., Andrews,R.G., Deeg,H.J., Appelbaum,F.R., Anasetti,C., Storb,R., & Sanders,J.E. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant, 33, 805-814 (2004) JMML de Vries,A.C., Bredius,R.G., Lankester,A.C., Bierings,M., Trebo,M., Sedlacek,P., Niemeyer,C.M., Zecca,M., Locatelli,F., & van den Heuvel-Eibrink MM. HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia. Haematologica 2009; 94: 302-304. Niemeyer,C.M.; Arico,M.; Basso,G.; Biondi,A.; Cantu Rajnoldi,A.; Creutzig,U.; Haas,O.; Harbott,J.; Hasle,H.; Kerndrup,G.; Locatelli, F.; Mann,G.; Stollmann-Gibbels,B.; van't Veer-Korthof,E.T.; van Wering,E.; Zimmermann,M. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood. 1997;89:3534- 3543. Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C, Pession A, Kabisch H, Uderzo C, Bonfim CS, Bader P, Dilloo D, Stary J, Fischer A, Revesz T, Fuhrer M, Hasle H, Trebo M, Heuvel-Eibrink MM, Fenu S, Strahm B, Giorgiani G, Bonora MR, Duffner U, Niemeyer CM. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005;105: 410-9. Yoshimi A, Bader P, Matthes-Martin S, Stary J, Sedlacek P, Duffner U, Klingebiel T, Dilloo D, Holter W, Zintl F, Kremens B, Sykora KW, Urban C, Hasle H, Korthof E, Revesz T, Fischer A, Nollke P, Locatelli F, Niemeyer CM. 48
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971-7. Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M, Sykora KW, Duffner U, Trebo M, Matthes-Martin S, Sedlacek P, Klingebiel T, Lang P, Fuhrer M, Claviez A, Wossmann W, Pession A, Arvidson J, O'Marcaigh AS, van den Heuvel-Eibrink MM, Stary J, Hasle H, Nollke P, Locatelli F, Niemeyer CM. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia 2007; 21: 556-60. 49
Page 1 and 2: Rekommandationer for knoglemarvstra
Page 3 and 4: Vævstyper og terminologi Ved valg
Page 5 and 6: 3.valg: 9/10 allel forligelig ubesl
Page 7 and 8: Petersdorf EW et al: Major-histocom
Page 9 and 10: Sygdomsspecifikke overvejelser & kr
Page 11 and 12: Non myeloablativ stamcelletransplan
Page 13 and 14: Akutte Leukæmier ALL hos voksne AL
Page 15 and 16: En metaanalyse af 7 studier, hvor a
Page 17 and 18: Højrisikofaktorer • Fænotype: N
Page 19 and 20: Kemoterapi Hoelzer, D.F (1993). The
Page 21 and 22: unrelated transplant in first compl
Page 23 and 24: ALL hos børn 5% blaster i knoglema
Page 25 and 26: i det nordamerikanske register, af
Page 27 and 28: Risikogrupper for AML i 1. CR Lavri
Page 29 and 30: Autolog KMT Litteraturen på områd
Page 31 and 32: Gale, R.P., Horowitz, M.M., Weiner,
Page 33 and 34: myelogenous leukemia in first compl
Page 35 and 36: AML hos børn
Page 37 and 38: Eapen M, Rubinstein P, Zhang MJ, Ca
Page 39 and 40: Point Parameter 0 0.5 1 1.5 2 Blast
Page 41 and 42: *) Specielt i denne gruppe gælder
Page 43 and 44: Kantarjian H, O'Brien S, Cortes J,
Page 45 and 46: Scott BL, Sandmaier BM, Storer B, M
Page 47: tiltagende. Patienter med RC og hø
Page 51 and 52: � Konstitutionelle symptomer, for
Page 53 and 54: Responskriterier ved CML Responstyp
Page 55 and 56: patienter, som statistisk set vil h
Page 57 and 58: Mauro,M.J. (2006) Defining and mana
Page 59 and 60: LYMFOMER Lymfoblastært lymfom Lymf
Page 61 and 62: Der er ingen data, der indicerer at
Page 63 and 64: BURKITT'S LYMFOM Senest revideret:
Page 65 and 66: Hoelzer D, Ludwig W-D, , Thiel E et
Page 67 and 68: Der er ikke indikation for autolog
Page 69 and 70: sequential chemotherapy in poor-ris
Page 71 and 72: af immunosuppressiv beh. og DLI og
Page 73 and 74: following high-dose sequential chem
Page 75 and 76: Marginal Zone Lymfom Senest revider
Page 77 and 78: Rezvani AR, Storer B, Maris M et al
Page 79 and 80: eskriver også sammenhæng mellem i
Page 81 and 82: HCT ved refraktær sygdom (Verdonck
Page 83 and 84: transplantation for lymphoprolifera
Page 85 and 86: Perifere T-Celle Lymfomer Senest re
Page 87 and 88: Referencer: Evens AM, Gartenhaus RB
Page 89 and 90: Hodgkin Lymfom (HL) Senest revidere
Page 91 and 92: Patienter med progressiv sygdom ell
Page 93 and 94: Transplant, 12,172-183. Anderlini,P
Page 95 and 96: Allogen KMT 1. HLA-identisk søsken
Page 97 and 98: Referencer Definition Bacigalupo A,
Page 99 and 100:
Paroxysmal Nocturn Haemoglobinuri,
Page 101 and 102:
Autolog transplantation Myelomatose
Page 103 and 104:
Cavo M, Tosi P, Zagmani E, Cellini
Page 105 and 106:
Myelofibrose Idiopatisk myelofibros
Page 107 and 108:
Introduktion Retransplantation af b
Page 109 and 110:
Den samlede konklusion kunne være,
Page 111 and 112:
Thalassæmier Senest revideret nove
Page 113 and 114:
thalassæmifri overlevelse på 66%
Page 115 and 116:
Kronisk granulomatøs sygdom Senest
show all

12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Create successful ePaper yourself

Delete template?

Save as template?